Skip to main content
OpenTrials

Clinical trial condition

Intrahepatic Cholangiocarcinoma (Icc)

Explore clinical trials studying Intrahepatic Cholangiocarcinoma (Icc). Study availability and eligibility vary by location and protocol.

36 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Intrahepatic Cholangiocarcinoma (Icc) trial results

Recruiting

A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

NCT05678270

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Beijing Youan Hosptital,Capital Medical University Beijing, Beijing Municipality, China
View all 44 locations
View Trial Details
Not yet recruiting

A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma

NCT07632235

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
Locations
  • Renji Hospital Shanghai, China
  • Sun Yat-sen University Cancer Center Guangzhou, China
  • Shanghai 10th People's Hospital Shanghai, China
  • Shanghai Sixth People's Hospital Shanghai, China
View Trial Details

Related conditions